These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 16914568)
1. CHEK2-positive breast cancers in young Polish women. Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Debniak T; Wokolorczyk D; Jakubowska A; Kowalska E; Oszurek O; Narod SA; Lubinski J Clin Cancer Res; 2006 Aug; 12(16):4832-5. PubMed ID: 16914568 [TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention. Cybulski C; Huzarski T; Byrski T; Gronwald J; Debniak T; Jakubowska A; Górski B; Wokołorczyk D; Masojć B; Narod SA; Lubiński J Clin Genet; 2009 Jan; 75(1):72-8. PubMed ID: 19021634 [TBL] [Abstract][Full Text] [Related]
3. A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland. Cybulski C; Wokołorczyk D; Huzarski T; Byrski T; Gronwald J; Górski B; Debniak T; Masojć B; Jakubowska A; van de Wetering T; Narod SA; Lubiński J Breast Cancer Res Treat; 2007 Mar; 102(1):119-22. PubMed ID: 16897426 [TBL] [Abstract][Full Text] [Related]
4. Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations. Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Debniak T; Wokolorczyk D; Jakubowska A; Serrano-Fernández P; Dork T; Narod SA; Lubinski J J Med Genet; 2009 Feb; 46(2):132-5. PubMed ID: 18930998 [TBL] [Abstract][Full Text] [Related]
5. Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. Cybulski C; Wokołorczyk D; Jakubowska A; Huzarski T; Byrski T; Gronwald J; Masojć B; Deebniak T; Górski B; Blecharz P; Narod SA; Lubiński J J Clin Oncol; 2011 Oct; 29(28):3747-52. PubMed ID: 21876083 [TBL] [Abstract][Full Text] [Related]
6. Pathology of breast cancer in women with constitutional CHEK2 mutations. Huzarski T; Cybulski C; Domagała W; Gronwald J; Byrski T; Szwiec M; Woyke S; Narod SA; Lubiński J Breast Cancer Res Treat; 2005 Mar; 90(2):187-9. PubMed ID: 15803365 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer predisposing alleles in Poland. Górski B; Cybulski C; Huzarski T; Byrski T; Gronwald J; Jakubowska A; Stawicka M; Gozdecka-Grodecka S; Szwiec M; Urbański K; Mituś J; Marczyk E; Dziuba J; Wandzel P; Surdyka D; Haus O; Janiszewska H; Debniak T; Tołoczko-Grabarek A; Medrek K; Masojć B; Mierzejewski M; Kowalska E; Narod SA; Lubiński J Breast Cancer Res Treat; 2005 Jul; 92(1):19-24. PubMed ID: 15980987 [TBL] [Abstract][Full Text] [Related]
8. Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer. Domagala P; Wokolorczyk D; Cybulski C; Huzarski T; Lubinski J; Domagala W Breast Cancer Res Treat; 2012 Apr; 132(3):937-45. PubMed ID: 21701879 [TBL] [Abstract][Full Text] [Related]
9. Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study. Zhang S; Phelan CM; Zhang P; Rousseau F; Ghadirian P; Robidoux A; Foulkes W; Hamel N; McCready D; Trudeau M; Lynch H; Horsman D; De Matsuda ML; Aziz Z; Gomes M; Costa MM; Liede A; Poll A; Sun P; Narod SA Cancer Res; 2008 Apr; 68(7):2154-7. PubMed ID: 18381420 [TBL] [Abstract][Full Text] [Related]
10. The contribution of founder mutations to early-onset breast cancer in French-Canadian women. Ghadirian P; Robidoux A; Zhang P; Royer R; Akbari M; Zhang S; Fafard E; Costa M; Martin G; Potvin C; Patocskai E; Larouche N; Younan R; Nassif E; Giroux S; Narod SA; Rousseau F; Foulkes WD Clin Genet; 2009 Nov; 76(5):421-6. PubMed ID: 19863560 [TBL] [Abstract][Full Text] [Related]
11. CDKN2A-positive breast cancers in young women from Poland. Debniak T; Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Jakubowska A; Kowalska E; Oszurek O; Narod SA; Lubiński J Breast Cancer Res Treat; 2007 Jul; 103(3):355-9. PubMed ID: 17061045 [TBL] [Abstract][Full Text] [Related]
13. Breast cancer in patients carrying a germ-line CHEK2 mutation: Outcome after breast conserving surgery and adjuvant radiotherapy. Meyer A; Dörk T; Sohn C; Karstens JH; Bremer M Radiother Oncol; 2007 Mar; 82(3):349-53. PubMed ID: 17250914 [TBL] [Abstract][Full Text] [Related]
14. Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations? Cybulski C; Wokołorczyk D; Kładny J; Kurzawski G; Suchy J; Grabowska E; Gronwald J; Huzarski T; Byrski T; Górski B; D Ecedil Bniak T; Narod SA; Lubiński J Eur J Hum Genet; 2007 Feb; 15(2):237-41. PubMed ID: 17106448 [TBL] [Abstract][Full Text] [Related]
15. CHEK2 1100delC, IVS2+1G>A and I157T mutations are not present in colorectal cancer cases from Turkish population. Bayram S; Topaktaş M; Akkız H; Bekar A; Akgöllü E Cancer Epidemiol; 2012 Oct; 36(5):453-7. PubMed ID: 22521562 [TBL] [Abstract][Full Text] [Related]
16. Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer. Laitman Y; Kaufman B; Lahad EL; Papa MZ; Friedman E Isr Med Assoc J; 2007 Nov; 9(11):791-6. PubMed ID: 18085035 [TBL] [Abstract][Full Text] [Related]
17. CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. Weischer M; Bojesen SE; Ellervik C; Tybjaerg-Hansen A; Nordestgaard BG J Clin Oncol; 2008 Feb; 26(4):542-8. PubMed ID: 18172190 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation. Schmidt MK; Tollenaar RA; de Kemp SR; Broeks A; Cornelisse CJ; Smit VT; Peterse JL; van Leeuwen FE; Van't Veer LJ J Clin Oncol; 2007 Jan; 25(1):64-9. PubMed ID: 17132695 [TBL] [Abstract][Full Text] [Related]
19. Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk. Serrano-Fernández P; Debniak T; Górski B; Bogdanova N; Dörk T; Cybulski C; Huzarski T; Byrski T; Gronwald J; Wokołorczyk D; Narod SA; Lubiński J Breast Cancer Res Treat; 2009 Sep; 117(1):161-5. PubMed ID: 19030985 [TBL] [Abstract][Full Text] [Related]
20. Excess breast cancer risk in first degree relatives of CHEK2∗1100delC positive familial breast cancer cases. Adank MA; Verhoef S; Oldenburg RA; Schmidt MK; Hooning MJ; Martens JW; Broeks A; Rookus M; Waisfisz Q; Witte BI; Jonker MA; Meijers-Heijboer H Eur J Cancer; 2013 May; 49(8):1993-9. PubMed ID: 23415889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]